Biopharmaceutical company.
H.R. 9: Innovation Act, including proposed changes to the Inter Partes Review (IPR) process at the Patent and Trademark Office (PTO). H.R. 1101: Viral Hepatitis Testing Act.

Increased appropriations for Viral Hepatitis Testing for CDC and VA.

Implementation of Affordable Care Act as it relates to a regulatory pathway for biosimilars, including patent dispute resolution.

H.R. 6: 21st Century Cures Act, including inclusion of H.R. 971: OPEN Act.

Education about the value of innovative new medicines.

Education about the 340(b) program. Education and outreach about the competitive elements of the Medicare Part D drug benefit and opposition to legislation imposing Medicaid style manufacturer rebates in the program.
CPT - Copyright/Patent/Trademark HCR - Health Issues MMM - Medicare/Medicaid
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
W STRATEGIES, LLC
1455 Pennsylvania Avenue, NW, Suite 400, Washington, DC, 20004, US
DARREN WILLCOX DARREN WILLCOX DARREN WILLCOX